The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference-Reference-Cited by-同舟云学术

The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Published:2024-06 Issue: Volume: Page:
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Vivarelli Marina^ORCID,Barratt Jonathan^ORCID,Beck Laurence H.,Fakhouri Fadi,Gale Daniel P.^ORCID,Goicoechea de Jorge Elena,Mosca Marta,Noris Marina^ORCID,Pickering Matthew C.^ORCID,Susztak Katalin^ORCID,Thurman Joshua M.,Cheung Michael^ORCID,King Jennifer M.,Jadoul Michel^ORCID,Winkelmayer Wolfgang C.^ORCID,Smith Richard J.H.,Alberici Federico,Antonucci Luca,Avcin Tadej,Bagga Arvind,Bajema Ingeborg M.,Blasco Miquel,Chauvet Sophie,Cook H. Terence,Cravedi Paolo,Dragon-Durey Marie-Agnès,Fischer Lauren,Fogo Agnes B.,Frazer-Abel Ashley,Frémeaux-Bacchi Véronique,Görlich Nina,Haas Mark,Humphreys Alister,Jha Vivekanand,Jauhal Arenn,Kavanagh David,Kronbichler Andreas,Lafayette Richard A.,Lanning Lynne D.,Lemaire Mathieu,Le Quintrec Moglie,Licht Christoph,Liew Adrian,McAdoo Steve,Medjeral-Thomas Nicholas R.,Meroni Pier Luigi,Morelle Johann,Nester Carla M.,Praga Manuel,Ramachandran Raja,Reich Heather N.,Remuzzi Giuseppe,Rodríguez de Córdoba Santiago,Robinson Gary,Ronco Pierre,Rossing Peter,Salant David J.,Sethi Sanjeev,Silkjaer Marianne,Song Wen-chao,Spoleti Fabrizio,Taylor Ronald P.,van de Kar Nicole C.A.J.,van Kooten Cees,Woodward Len,Zhang Yuzhou,Zipfel Peter F.,Zuccato Marco

Publisher

Elsevier BV

Reference199 articles.

1. Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference;Goodship;Kidney Int,2017

2. Complement and the kidney: an overview;Thurman;Adv Chronic Kidney Dis,2020

3. Complement inhibitors in clinical trials for glomerular diseases;Zipfel;Front Immunol,2019

4. Clinical safety and efficacy of pegcetacoplan in a Phase 2 study of patients with C3 glomerulopathy and other complement-mediated glomerular diseases;Dixon;Kidney Int Rep,2023

5. Phase 2 trial of cemdisiran in adult patients with IgA nephropathy: a randomized controlled trial;Barratt;Clin J Am Soc Nephrol,2024

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How Stem and Progenitor Cells Can Affect Renal Diseases;Cells;2024-08-30

2. Complement anaphylatoxins: Potential therapeutic target for diabetic kidney disease;Diabetic Medicine;2024-08-27

3. Kidney transplantation in children and adolescents with C3 glomerulopathy or immune complex membranoproliferative glomerulonephritis: a real-world study within the CERTAIN research network;Pediatric Nephrology;2024-08-07